$AMCR

Is Amcor Stock Underperforming the Dow?

Amcor plc (AMCR), a $19B packaging company, has lagged the Dow: down 19.4% from its 52-week high ($50.94) and down 9.2% over 52 weeks versus the Dow’s 22.3% gain. After Q2 2026 results on May 6, shares rose 6.8% as revenue hit $5.9B and adjusted EPS was $0.96; full-year EPS guidance is $3.98–$4.03. Analysts rate AMCR a “Moderate Buy” with a $47.94 mean target.

Original reporting
Published Jun 20, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 20, 2026, 12:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Amcor Stock Underperforming the Dow? — source image
Decision brief

The 30-second read

$AMCRNeutralLow
01

Why it matters

The only concrete fundamental datapoints are Q2 2026 revenue/EPS and the full-year EPS range; the rest is relative performance and moving-average context, which is more useful for positioning than for a new fundamental decision.

02

Market read

Useful for confirming the latest cited earnings/guidance and for technical/relative-strength context, but it does not introduce a new catalyst beyond what the earnings release already provided.

03

What to watch

The article doesn’t discuss margin drivers, backlog/order trends, or segment-level guidance changes—key items traders would need to judge whether the guidance range implies upside beyond the consensus PT.

Relevance 4/10Novelty 4/10Timing: after-hours/next-session positioning based on reiterated Q2 results and guidance (earnings referenced from May 6)

Background

Amcor is a large-cap packaging company with flexible and rigid packaging segments; the article compares its stock performance to the Dow and summarizes its Q2 2026 results and guidance.

Company-level read

Ticker impact

$AMCRNeutralMedium confidence
Context

Article frames Amcor’s relative performance vs the Dow and notes its Q2 2026 earnings beat plus full-year EPS guidance range.

Expected impact

Limited incremental impact; any trading effect is likely already priced given the earnings date cited (May 6).

Evidence & confidence

It provides specific Q2 revenue/EPS and full-year EPS guidance, but the newest catalyst referenced is not same-day and the rest is comparative/technical context rather than a fresh disclosure.

Market effects

Packaging/containers demand expectations may be indirectly supported by the earnings beat and maintained full-year EPS range, but no new sector catalyst is introduced.

No new regional policy or demand shock; discussion is performance-based vs US benchmark.

No new global trade/regulatory development; only company-specific performance and guidance are referenced.

Counterpoint

Underperformance vs the Dow over 52 weeks and trading below the 200-day moving average could signal the market is discounting longer-term fundamentals despite the earnings beat.

Key entities

  • Amcor plc

    Packaging producer; article cites Q2 2026 earnings beat and full-year EPS guidance range, plus relative underperformance vs the Dow.

Related articles

$AMCRMed

Amcor Boosts India Output for Healthcare Packaging

Amcor (NYSE: AMCR, ASX: AMC) said it is making a further multi-million-dollar investment in its Sira, Karnataka, India healthcare packaging plant to add a new production line. The company expects higher capacity and shorter lead times for ophthalmic containers and injectable vials, using automated vision systems and more energy-efficient equipment. The facility runs on 100% renewable energy and is ISCC PLUS certified; the expansion will add 30+ jobs.

$AMCRMedAI 8/10

Income Safe-Haven Under $40: Why This Packaging Giant’s 5.8% Yield Is Mispriced

Amcor (AMCR) shares closed at $38.38 on May 22, 2026, with a forward dividend yield of about 5.87%. The company guides for 12% adjusted EPS growth in FY and has raised its dividend 1.96% year over year, paying $0.65 quarterly (next due June 17, 2026). After closing Berry Global’s acquisition on April 30, 2025, Amcor’s consensus price target is $48.21 and Truist reiterated Buy with a $60 target.

$AMCRMedAI 8/10

Is Amcor (AMCR) One of the Top 10 Dividend Aristocrat Stocks Ranked by Yield?

Amcor plc (NYSE:AMCR) is listed among Dividend Aristocrats Ranked by Yield, with an annual dividend yield of 6.62% as of May 29. On May 20, Wells Fargo cut its price target to $41 from $43 and kept an Equal Weight rating, citing merger synergies, leverage reduction, and limited visibility on volume trends. In its fiscal Q3 2026 call, Amcor guided adjusted EPS for 2026 at $3.98–$4.03 and free cash flow at $1.5–$1.6 billion.

$AMCRLowAI 8/10

New Jersey Rep. Tom Kean Jr. ditched Congress for 75 days citing illness. Someone went digging and found out exactly what he's been up to.

New Jersey Rep. Tom Kean Jr. has been absent from Congress for 75 days, citing illness, but records cited by The New Republic and NOTUS say he traveled and traded stocks during the period. He skipped 88 House votes since March 5. NOTUS reports trades in Amcor, Chubb, First Citizens BancShares, Johnson & Johnson, and PepsiCo totaling $50,008–$190,000.

$SMCIMed

Super Micro Computer Landed $60 Billion in Orders Last Quarter, but Trades at Just $30

Super Micro Computer (SMCI) said it booked over $60B in new orders in its fiscal Q4 ended June 30, lifting backlog to a record. It guided FY2026 revenue near the low end of $11B to $12.5B and gross margins at 15% to 17%. The company also plans $7B equity financing for AI server orders, noting some orders may not be firm and citing an independent review tied to export control issues.